patients was HCV eradicated, because, in the remain-weakly positive) before therapy have a high rate of sustained response when treated with interferon, in der, HCV RNA was apparently negative from the beginning. Thus, cure was achieved with the aggressive our experience, these patients do not show
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
β Scribed by Stefano Bellentani; Claudio Tiribelli; Gioconda Saccoccio; Marino Sodde; Nicoletta Fratti; Christina De Martin; Giovanni Christianini
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 903 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Data on the prevalence of chronic liver disease, derived from selected series of hospitalized patients or from mortality registers, underestimate the prevalence of chronic liver disease. The Dionysos Study is a cohort study that investigated for the first time the prevalence of chronic liver disease in a general population. All the citizens of two towns in northern Italy, Campogalliano and Cormons, aged 12 to 65 yr were contacted by letter. From March 1991 through March 1993, 6,917 of a total of 10,150 citizens were enrolled (compliance, 69%). The standardized protocol for each enrollee included (a) a color-illustrated food questionnaire on dietary habits and alcohol intake; (b) a detailed medical history, including questions on risk factors for chronic liver disease; (c) a physical examination; and (d) blood tests for AST, ALT, y-glutamyltranspeptidase, mean cell volume, platelet count and hepatitis B virus and hepatitis C virus markers. Signs suggestive of chronic liver disease were seen in 21.3% of the subjects, and who then underwent further liver function tests, upper abdominal ultrasonography and, when necessary, liver biopsy. Persistent signs of chronic liver disease were present in 17.5% of the was the etiological agent in 23%. Other factors which predisposed subjects to chronic liver disease were age older than 35 yr, male sex, body mass index higher than 27, history of blood transfusion, drug addiction and presence of chronic liver disease in the subject's family. Cirrhosis was due to hepatitis B virus or hepatitis C virus in 37%, and alcohol was the cause in 26%. In those subjects with alcohol abuse, viral infection, especially hepatitis C virus, played an important role in the deterioration of chronic liver disease and its progression to hepatocellular carcinoma. We conclude that the Dionysos study, the first study of the prevalence of chronic liver disease in a general population of northern Italy, found a much higher prevalence of chronic liver disease than reported previously in selected populations from Western countries. Hepatitis viral infections and alcoholism were the most important causative agents.
π SIMILAR VOLUMES
Using the general population of the Dionysos Study, we followed up 144 subjects without fatty liver (FL Ψ ) and 336 with fatty liver (FL Ψ ) for a median time of 8.5 years. All subjects had suspected liver disease (SLD) defined as altered liver enzymes, high mean corpuscular volume, or low platelet
## Abstract Knowledge of the current epidemiology of chronic liver disease in Italy is mostly obsolete and fragmentary for the lack of upβtoβdate consistent data. In 2001, a 6βmonth prevalence study was undertaken in 79 hospitals to assess the characteristics of chronic liver disease in Italy. Both
## Abstract The prevalence and characteristics of parkinsonism have been assessed in two separate geographic areas in Italy (Arcisate and San Giovanni Rotondo). A total of 28, 377 patients of 23 general practitioners (GPs) were the reference population. Fiftyβeight patients were traced by the GP as
To investigate the prevalence and incidence of cholecystolithiasis in hepatitis B surface antigen-positive chronic liver diseases, a prospective study using hepatobiliary ultrasonography was conducted in 933 "healthy" persons and four groups of HBsAg-positive patients: 226 asymptomatic carriers, 73